# Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

> **NCT06155409** · — · ACTIVE_NOT_RECRUITING · sponsor: **SPINEVISION SAS** · enrollment: 148 (actual)

## Conditions studied

- Intervertebral Disc Degeneration

## Interventions

- **DEVICE:** Anterior cervical interbody fusion

## Key facts

- **NCT ID:** NCT06155409
- **Lead sponsor:** SPINEVISION SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-06
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155409, "Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06155409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*